Lipitor Clinical Trials Lipitor RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients
Condition:   Atherosclerotic Cardiovascular Disease Interventions:   Drug: Atozet 10/40 mg or 10/80 mg;   Drug: Lipitor 40 mg or 80 mg Sponsors:   Organon and Co;   Iqvia Pty Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2023 Category: Research Source Type: clinical trials